• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemical inhibition of DPP9 sensitizes the CARD8 inflammasome in HIV-1-infected cells.化学抑制 DPP9 可增强 HIV-1 感染细胞中的 CARD8 炎性小体。
Nat Chem Biol. 2023 Apr;19(4):431-439. doi: 10.1038/s41589-022-01182-5. Epub 2022 Nov 10.
2
CARD8 Inflammasome Activation by HIV-1 Protease.HIV-1蛋白酶激活CARD8炎性小体
Methods Mol Biol. 2023;2641:67-79. doi: 10.1007/978-1-0716-3040-2_6.
3
The CARD8 inflammasome in HIV infection.HIV 感染中的 CARD8 炎性小体。
Adv Immunol. 2023;157:59-100. doi: 10.1016/bs.ai.2022.11.001. Epub 2023 Mar 13.
4
CARD8 is an inflammasome sensor for HIV-1 protease activity.CARD8 是 HIV-1 蛋白酶活性的炎症小体传感器。
Science. 2021 Mar 19;371(6535). doi: 10.1126/science.abe1707. Epub 2021 Feb 4.
5
Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.二肽基肽酶 9 通过隔离其活性 C 末端片段来设定 CARD8 炎症小体形成的阈值。
Immunity. 2021 Jul 13;54(7):1392-1404.e10. doi: 10.1016/j.immuni.2021.04.024. Epub 2021 May 20.
6
Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs.超越抑制:靶向 HIV-1 蛋白酶消除病毒储存库的新策略。
Viruses. 2022 May 28;14(6):1179. doi: 10.3390/v14061179.
7
NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal.NNRTI 诱导的 HIV-1 蛋白酶介导的细胞毒性在生产性感染和潜伏逆转期间诱导 CD4 T 细胞的快速死亡。
Retrovirology. 2019 Jun 26;16(1):17. doi: 10.1186/s12977-019-0479-9.
8
Prevalence and outcomes of recycling NNRTIs despite documented NNRTI resistance in HIV-infected children and youth.尽管有记录显示 HIV 感染儿童和青少年对 NNRTI 具有耐药性,但 NNRTI 再循环的流行率和结局。
AIDS Patient Care STDS. 2014 Jan;28(1):10-4. doi: 10.1089/apc.2013.0308.
9
Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.与非核苷类逆转录酶抑制剂耐药相关的突变的汇编与流行情况
Antivir Ther. 2009;14(1):103-9.
10
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.非核苷类逆转录酶抑制剂诱导 HIV 蛋白酶激活选择性杀伤感染 HIV 的细胞。
Retrovirology. 2010 Oct 15;7:89. doi: 10.1186/1742-4690-7-89.

引用本文的文献

1
Mechanistic basis for a novel dual-function Gag-Pol dimerizer potentiating CARD8 inflammasome activation and clearance of HIV-infected cells.一种新型双功能Gag-Pol二聚体增强CARD8炎性小体激活及清除HIV感染细胞的机制基础。
NPJ Drug Discov. 2025;2(1):22. doi: 10.1038/s44386-025-00025-2. Epub 2025 Sep 1.
2
CARD8 inflammasome activation during HIV-1 cell-to-cell transmission.HIV-1细胞间传播过程中的CARD8炎性小体激活
Elife. 2025 Jun 16;13:RP102676. doi: 10.7554/eLife.102676.
3
The multifunctional regulatory post-proline protease dipeptidyl peptidase 9 and its inhibitors: new opportunities for therapeutics.多功能调节性脯氨酸后蛋白酶二肽基肽酶9及其抑制剂:治疗的新机遇
Cell Mol Life Sci. 2025 Apr 28;82(1):187. doi: 10.1007/s00018-025-05719-4.
4
Targeting inflammasomes as a therapeutic potential for HIV/AIDS.将炎性小体作为治疗HIV/AIDS的潜在靶点。
Cell Mol Life Sci. 2025 Apr 17;82(1):162. doi: 10.1007/s00018-025-05685-x.
5
GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets.Gasdermin D介导的细胞焦亡:分子机制、疾病及治疗靶点
Mol Biomed. 2025 Feb 25;6(1):11. doi: 10.1186/s43556-025-00249-8.
6
Activation and evasion of inflammasomes during viral and microbial infection.病毒和微生物感染期间炎性小体的激活与逃逸
Cell Mol Life Sci. 2025 Jan 21;82(1):56. doi: 10.1007/s00018-025-05575-2.
7
Mechanism and Kinetics of HIV-1 Protease Activation.HIV-1蛋白酶激活的机制与动力学
Viruses. 2024 Nov 25;16(12):1826. doi: 10.3390/v16121826.
8
Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.异维 A 酸可促进 CD4T 细胞中具有翻译能力的 HIV 潜伏储库的清除。
PLoS Pathog. 2024 Oct 14;20(10):e1012601. doi: 10.1371/journal.ppat.1012601. eCollection 2024 Oct.
9
Cosolvent Molecular Dynamics Applied to DPP4, DPP8 and DPP9: Reproduction of Important Binding Features and Use in Inhibitor Design.共溶剂分子动力学在 DPP4、DPP8 和 DPP9 中的应用:重现重要的结合特征并用于抑制剂设计。
J Chem Inf Model. 2024 Oct 14;64(19):7650-7665. doi: 10.1021/acs.jcim.4c01167. Epub 2024 Sep 27.
10
Inflammasome components as new therapeutic targets in inflammatory disease.炎症小体成分作为炎症性疾病的新治疗靶点。
Nat Rev Immunol. 2025 Jan;25(1):22-41. doi: 10.1038/s41577-024-01075-9. Epub 2024 Sep 9.

本文引用的文献

1
A ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome.泛素非依赖的蛋白酶体通路调控 CARD8 炎性小体的激活。
J Biol Chem. 2022 Jul;298(7):102032. doi: 10.1016/j.jbc.2022.102032. Epub 2022 May 14.
2
M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.M24B 氨肽酶抑制剂选择性激活 CARD8 炎性小体。
Nat Chem Biol. 2022 May;18(5):565-574. doi: 10.1038/s41589-021-00964-7. Epub 2022 Feb 14.
3
Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.二肽基肽酶 9 通过隔离其活性 C 末端片段来设定 CARD8 炎症小体形成的阈值。
Immunity. 2021 Jul 13;54(7):1392-1404.e10. doi: 10.1016/j.immuni.2021.04.024. Epub 2021 May 20.
4
DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.DPP9 隔离 NLRP1 的 C 末端以抑制炎症小体的激活。
Nature. 2021 Apr;592(7856):778-783. doi: 10.1038/s41586-021-03350-4. Epub 2021 Mar 17.
5
CARD8 is an inflammasome sensor for HIV-1 protease activity.CARD8 是 HIV-1 蛋白酶活性的炎症小体传感器。
Science. 2021 Mar 19;371(6535). doi: 10.1126/science.abe1707. Epub 2021 Feb 4.
6
CARD8 inflammasome activation triggers pyroptosis in human T cells.CARD8 炎性小体激活导致人 T 细胞发生细胞焦亡。
EMBO J. 2020 Oct 1;39(19):e105071. doi: 10.15252/embj.2020105071. Epub 2020 Aug 25.
7
DPP8/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes.DPP8/9 抑制剂在静止淋巴细胞中激活 CARD8 炎性体。
Cell Death Dis. 2020 Aug 14;11(8):628. doi: 10.1038/s41419-020-02865-4.
8
SynergyFinder 2.0: visual analytics of multi-drug combination synergies.SynergyFinder 2.0:多药物组合协同作用的可视化分析。
Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493. doi: 10.1093/nar/gkaa216.
9
DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.DPP9 的酶活性而非其与 CARD8 的结合抑制炎症小体的激活。
ACS Chem Biol. 2019 Nov 15;14(11):2424-2429. doi: 10.1021/acschembio.9b00462. Epub 2019 Sep 20.
10
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.HIV-1 缓解后 CCR5Δ32/Δ32 造血干细胞移植。
Nature. 2019 Apr;568(7751):244-248. doi: 10.1038/s41586-019-1027-4. Epub 2019 Mar 5.

化学抑制 DPP9 可增强 HIV-1 感染细胞中的 CARD8 炎性小体。

Chemical inhibition of DPP9 sensitizes the CARD8 inflammasome in HIV-1-infected cells.

机构信息

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.

Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA.

出版信息

Nat Chem Biol. 2023 Apr;19(4):431-439. doi: 10.1038/s41589-022-01182-5. Epub 2022 Nov 10.

DOI:10.1038/s41589-022-01182-5
PMID:36357533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10065922/
Abstract

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) induce pyroptosis of HIV-1-infected CD4 T cells through induction of intracellular HIV-1 protease activity, which activates the CARD8 inflammasome. Because high concentrations of NNRTIs are required for efficient elimination of HIV-1-infected cells, it is important to elucidate ways to sensitize the CARD8 inflammasome to NNRTI-induced activation. We show that this sensitization can be achieved through chemical inhibition of the CARD8 negative regulator DPP9. The DPP9 inhibitor Val-boroPro (VbP) can kill HIV-1-infected cells without the presence of NNRTIs and act synergistically with NNRTIs to promote clearance of HIV-1-infected cells in vitro and in humanized mice. More importantly, VbP is able to enhance clearance of residual HIV-1 in CD4 T cells isolated from people living with HIV (PLWH). We also show that VbP can partially overcome NNRTI resistance. This offers a promising strategy for enhancing NNRTI efficacy in the elimination of HIV-1 reservoirs in PLWH.

摘要

非核苷类逆转录酶抑制剂(NNRTIs)通过诱导细胞内 HIV-1 蛋白酶活性诱导 HIV-1 感染的 CD4 T 细胞发生细胞焦亡,从而激活 CARD8 炎性小体。由于需要高浓度的 NNRTIs 才能有效清除 HIV-1 感染的细胞,因此阐明使 CARD8 炎性小体对 NNRTI 诱导的激活敏感的方法非常重要。我们表明,通过化学抑制 CARD8 的负调节剂 DPP9 可以实现这种敏化。DPP9 抑制剂 Val-boroPro(VbP)可以在没有 NNRTIs 的情况下杀死 HIV-1 感染的细胞,并与 NNRTIs 协同作用,促进体外和人源化小鼠中 HIV-1 感染细胞的清除。更重要的是,VbP 能够增强从 HIV 感染者(PLWH)中分离的 CD4 T 细胞中清除残余 HIV-1 的能力。我们还表明,VbP 可以部分克服 NNRTI 耐药性。这为增强 NNRTI 清除 PLWH 中 HIV-1 储存库的疗效提供了一种有前途的策略。